InsiderTrades.com logo
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
From Crypto Swap Profits   |   Ad
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
Register for the FREE Workshop Now & get $10 in Bitcoin

ARWR Insider Trading

Insider Ownership Percentage: 4.50%
Insider Buying (Last 12 Months): $54,990.00
Insider Selling (Last 12 Months): $7,898,458.13

Arrowhead Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Arrowhead Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Arrowhead Pharmaceuticals Share Price & Price History

Current Price: $19.45
Price Change: ▼ Price Decrease of -0.05 (-0.26%)
As of 12/20/2024 06:15 PM ET

This chart shows the closing price history over time for ARWR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong
From Brownstone Research   |   Ad
Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.
Click here to watch this demo and decide for yourself.

Arrowhead Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/18/2024Christopher Richard AnzaloneCEOSell26,712$21.24$567,362.883,688,335View SEC Filing Icon  
12/16/2024William D. WaddillDirectorSell3,748$21.90$82,081.2044,125View SEC Filing Icon  
7/2/2024Tracie OliverInsiderSell9,394$25.28$237,480.32127,107View SEC Filing Icon  
5/2/2024Victoria VakienerDirectorSell1,799$23.31$41,934.6930,205View SEC Filing Icon  
3/20/2024Hongbo LuDirectorBuy1,000$27.50$27,500.0033,680View SEC Filing Icon  
3/18/2024Hongbo LuDirectorBuy1,000$27.49$27,490.0031,680View SEC Filing Icon  
3/6/2024Kenneth Allen MyszkowskiCFOSell40,000$35.19$1,407,600.00400,600View SEC Filing Icon  
1/31/2024Christopher Richard AnzaloneCEOSell57,499$32.35$1,860,092.653,715,048View SEC Filing Icon  
1/12/2024James C. HamiltonInsiderSell7,940$36.89$292,906.60210,851View SEC Filing Icon  
1/11/2024Douglas B GivenDirectorSell2,911$38.06$110,792.66129,711View SEC Filing Icon  
1/5/2024James C. HamiltonInsiderSell32,143$35.18$1,130,790.74218,791View SEC Filing Icon  
1/5/2024Kenneth Allen MyszkowskiCFOSell16,104$35.27$567,988.08440,600View SEC Filing Icon  
1/5/2024Patrick C. O'BrienCOOSell22,841$35.27$805,602.07464,385View SEC Filing Icon  
1/3/2024James C. HamiltonInsiderSell6,300$32.19$202,797.00175,934View SEC Filing Icon  
1/3/2024Patrick C. O'BrienCOOSell8,749$32.28$282,417.72403,826View SEC Filing Icon  
1/2/2024Christopher Richard AnzaloneCEOSell9,952$31.01$308,611.523,715,048View SEC Filing Icon  
12/20/2023Christopher Richard AnzaloneCEOSell12,000$28.54$342,480.003,725,000View SEC Filing Icon  
11/20/2023Javier San MartinInsiderSell19,700$28.80$567,360.00131,800View SEC Filing Icon  
10/25/2023Christopher Richard AnzaloneCEOSell24,338$24.21$589,222.983,737,000View SEC Filing Icon  
9/28/2023Victoria VakienerDirectorSell1,550$26.33$40,811.5021,734View SEC Filing Icon  
9/18/2023Christopher Richard AnzaloneCEOSell57,755$28.12$1,624,070.603,761,338View SEC Filing Icon  
7/3/2023Tracie OliverInsiderSell8,925$35.31$315,141.7561,575View SEC Filing Icon  
6/30/2023James C. HamiltonInsiderSell3,000$35.53$106,590.00188,484View SEC Filing Icon  
6/27/2023Kenneth Allen MyszkowskiCFOSell15,000$36.20$543,000.00381,704View SEC Filing Icon  
5/5/2023Douglas B GivenDirectorSell6,500$40.90$265,850.00117,635View SEC Filing Icon  
5/3/2023Christopher Richard AnzaloneCEOSell54,928$39.14$2,149,881.923,761,338View SEC Filing Icon  
3/3/2023Adeoye Y. OlukotunDirectorSell11,350$32.65$370,577.507,867View SEC Filing Icon  
2/27/2023Douglas B GivenDirectorSell875$32.62$28,542.5013,000View SEC Filing Icon  
1/9/2023William D. WaddillDirectorSell3,200$30.00$96,000.0028,950View SEC Filing Icon  
1/5/2023James C. HamiltonInsiderSell13,803$37.40$516,232.20191,484View SEC Filing Icon  
1/5/2023Patrick C. O'BrienCOOSell15,000$37.39$560,850.00413,375View SEC Filing Icon  
1/3/2023James C. HamiltonInsiderSell10,338$38.38$396,772.44145,287View SEC Filing Icon  
1/3/2023Patrick C. O'BrienCOOSell17,500$38.33$670,775.00363,375View SEC Filing Icon  
12/29/2022Kenneth Allen MyszkowskiCFOSell30,625$40.00$1,225,000.00336,704View SEC Filing Icon  
11/21/2022Javier San MartinInsiderSell19,500$29.99$584,805.0091,500View SEC Filing Icon  
2/11/2022Christopher Richard AnzaloneCEOSell146,388$51.91$7,599,001.08View SEC Filing Icon  
1/5/2022Kenneth Allen MyszkowskiCFOSell40,000$61.70$2,468,000.00View SEC Filing Icon  
1/5/2022Patrick C. O'BrienGeneral CounselSell32,500$61.72$2,005,900.00View SEC Filing Icon  
1/4/2022James C. HamiltonSVPSell19,375$65.49$1,268,868.75View SEC Filing Icon  
1/3/2022William D. WaddillDirectorSell4,500$64.72$291,240.00View SEC Filing Icon  
12/28/2021Douglas B GivenDirectorBuy655$66.37$43,472.35View SEC Filing Icon  
See Full Table
Amazon coin set to soar 25X – starting December 16th?
From True Market Insiders   |   Ad
This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team of crypto experts has identified it as the most promising crypto of 2024. You can see all of the details surrounding the #1 Crypto of 2024
>3-Cent Amazon Coin<

SEC Filings (Institutional Ownership Changes) for Arrowhead Pharmaceuticals (NASDAQ:ARWR)

62.61% of Arrowhead Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ARWR by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Arrowhead Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/19/2024Principal Financial Group Inc.290,994$5.64M0.0%-31.5%0.234%Search for SEC Filing on Google Icon
12/6/2024Retirement Systems of Alabama151,012$2.93M0.0%-1.5%0.121%Search for SEC Filing on Google Icon
11/27/2024Franklin Resources Inc.19,251$0.37M0.0%+9.4%0.015%Search for SEC Filing on Google Icon
11/25/2024World Investment Advisors LLC19,132$0.37M0.0%+3.8%0.015%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC2,964,119$57.43M0.0%+0.9%2.384%Search for SEC Filing on Google Icon
11/15/2024Y Intercept Hong Kong Ltd17,795$0.35M0.0%N/A0.014%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC463,880$8.99M0.0%-18.0%0.373%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP61,904$1.20M0.0%+1.5%0.050%Search for SEC Filing on Google Icon
11/15/2024State Street Corp6,354,331$123.08M0.0%+8.8%5.111%Search for SEC Filing on Google Icon
11/15/2024Quarry LP6,500$0.13M0.0%-23.5%0.005%Search for SEC Filing on Google Icon
11/15/2024Janus Henderson Group PLC49,845$0.97M0.0%-12.3%0.040%Search for SEC Filing on Google Icon
11/15/2024HighTower Advisors LLC123,477$2.40M0.0%+11.5%0.099%Search for SEC Filing on Google Icon
11/15/2024Erste Asset Management GmbH47,000$0.92M0.0%N/A0.038%Search for SEC Filing on Google Icon
11/14/2024PDT Partners LLC16,241$0.32M0.0%N/A0.013%Search for SEC Filing on Google Icon
11/14/2024Verition Fund Management LLC76,548$1.48M0.0%+80.7%0.062%Search for SEC Filing on Google Icon
11/14/2024Captrust Financial Advisors15,039$0.29M0.0%N/A0.012%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC2,154,250$41.73M0.0%-5.9%1.733%Search for SEC Filing on Google Icon
11/14/2024Zurcher Kantonalbank Zurich Cantonalbank30,262$0.59M0.0%+5.3%0.024%Search for SEC Filing on Google Icon
11/14/2024MetLife Investment Management LLC131,029$2.54M0.0%-0.8%0.105%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets55,188$1.07M0.0%+40.1%0.044%Search for SEC Filing on Google Icon
11/13/2024Quantbot Technologies LP7,706$0.15M0.0%N/A0.006%Search for SEC Filing on Google Icon
11/13/2024FMR LLC6,067,569$117.53M0.0%-10.9%4.881%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company142,040$2.75M0.0%-4.8%0.114%Search for SEC Filing on Google Icon
11/13/2024Fisher Asset Management LLC122,260$2.37M0.0%+941.0%0.098%Search for SEC Filing on Google Icon
11/12/2024Algert Global LLC36,986$0.72M0.0%-8.6%0.030%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.1,006,935$19.50M0.0%+1.3%0.810%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC34,045$0.66M0.0%N/A0.027%Search for SEC Filing on Google Icon
11/8/2024Ontario Teachers Pension Plan Board16,690$0.32M0.0%-55.6%0.013%Search for SEC Filing on Google Icon
11/8/2024B. Metzler seel. Sohn & Co. Holding AG18,705$0.36M0.0%N/A0.015%Search for SEC Filing on Google Icon
11/7/2024Quest Partners LLC25,493$0.49M0.0%N/A0.021%Search for SEC Filing on Google Icon
11/7/2024Thrivent Financial for Lutherans29,206$0.57M0.0%-2.7%0.023%Search for SEC Filing on Google Icon
11/6/2024Mutual of America Capital Management LLC67,187$1.30M0.0%-5.5%0.054%Search for SEC Filing on Google Icon
11/5/2024Victory Capital Management Inc.39,251$0.76M0.0%-4.5%0.032%Search for SEC Filing on Google Icon
11/5/2024WCM Investment Management LLC219,962$4.33M0.0%-4.1%0.177%Search for SEC Filing on Google Icon
11/4/2024State of New Jersey Common Pension Fund D80,307$1.56M0.0%-1.2%0.065%Search for SEC Filing on Google Icon
11/2/2024Privium Fund Management B.V.333,356$6.46M1.6%+16.2%0.268%Search for SEC Filing on Google Icon
10/31/2024Principal Financial Group Inc.290,994$5.64M0.0%-31.5%0.234%Search for SEC Filing on Google Icon
10/30/2024Amalgamated Bank54,765$1.06M0.0%-8.8%0.044%Search for SEC Filing on Google Icon
10/29/2024Van ECK Associates Corp1,728$34K0.0%-42.0%0.001%Search for SEC Filing on Google Icon
10/28/2024Oak Ridge Investments LLC35,137$0.68M0.1%-4.0%0.028%Search for SEC Filing on Google Icon
10/28/2024US Bancorp DE40,123$0.78M0.0%-11.1%0.032%Search for SEC Filing on Google Icon
10/25/2024China Universal Asset Management Co. Ltd.23,910$0.46M0.1%+63.9%0.019%Search for SEC Filing on Google Icon
10/25/2024abrdn plc401,146$7.77M0.0%+61.3%0.323%Search for SEC Filing on Google Icon
10/24/2024Nisa Investment Advisors LLC1,840$36K0.0%-23.2%0.001%Search for SEC Filing on Google Icon
10/24/2024State of Alaska Department of Revenue14,417$0.28M0.0%+7.3%0.012%Search for SEC Filing on Google Icon
10/24/2024DekaBank Deutsche Girozentrale37,844$0.74M0.0%+4.4%0.030%Search for SEC Filing on Google Icon
10/24/2024Wealth Enhancement Advisory Services LLC14,498$0.28M0.0%+79.6%0.012%Search for SEC Filing on Google Icon
10/23/2024Mirae Asset Global Investments Co. Ltd.4,496$88K0.0%+21.3%0.004%Search for SEC Filing on Google Icon
10/23/2024Louisiana State Employees Retirement System34,500$0.67M0.0%-1.7%0.028%Search for SEC Filing on Google Icon
10/23/2024Values First Advisors Inc.2,685$52K0.0%N/A0.002%Search for SEC Filing on Google Icon
10/23/2024Assenagon Asset Management S.A.293,083$5.68M0.0%+232.5%0.236%Search for SEC Filing on Google Icon
10/23/2024Moody Aldrich Partners LLC48,961$0.95M0.2%-1.8%0.039%Search for SEC Filing on Google Icon
10/23/2024Hennion & Walsh Asset Management Inc.22,516$0.44M0.0%-9.5%0.018%Search for SEC Filing on Google Icon
10/22/2024International Assets Investment Management LLC74,439$14.42M0.0%N/A0.060%Search for SEC Filing on Google Icon
10/16/2024Buffington Mohr McNeal30,000$0.58M0.1%N/A0.024%Search for SEC Filing on Google Icon
10/11/2024Creative Planning25,409$0.49M0.0%-10.1%0.020%Search for SEC Filing on Google Icon
10/10/2024Exchange Traded Concepts LLC40,292$0.78M0.0%-17.7%0.032%Search for SEC Filing on Google Icon
10/5/2024Handelsbanken Fonder AB35,700$0.69M0.0%+17.0%0.029%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC35,206$0.68M0.0%+275.8%0.028%Search for SEC Filing on Google Icon
8/16/2024Quarry LP8,500$0.22M0.1%+54.5%0.007%Search for SEC Filing on Google Icon
8/16/2024Creative Planning28,276$0.74M0.0%+9.4%0.023%Search for SEC Filing on Google Icon
8/16/2024Algert Global LLC40,466$1.05M0.0%+104.3%0.033%Search for SEC Filing on Google Icon
8/15/2024Scientech Research LLC7,842$0.20M0.0%-48.5%0.006%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company149,156$3.88M0.0%+1.1%0.120%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC529,251$13.76M0.0%+61.9%0.426%Search for SEC Filing on Google Icon
8/15/2024Deerfield Management Company L.P. Series C19,461$0.51M0.0%N/A0.016%Search for SEC Filing on Google Icon
8/15/2024Affinity Asset Advisors LLC50,000$1.30M0.1%-58.3%0.040%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC383,826$9.98M0.0%N/A0.309%Search for SEC Filing on Google Icon
8/14/2024Xponance Inc.16,465$0.43M0.0%-4.8%0.013%Search for SEC Filing on Google Icon
8/14/2024Bank of Montreal Can43,699$1.20M0.0%+240.5%0.035%Search for SEC Filing on Google Icon
8/14/2024Avoro Capital Advisors LLC8,888,888$231.02M3.1%+3.9%7.157%Search for SEC Filing on Google Icon
8/14/2024ProShare Advisors LLC29,081$0.76M0.0%-18.3%0.023%Search for SEC Filing on Google Icon
8/14/2024Profund Advisors LLC32,003$0.83M0.0%-34.6%0.026%Search for SEC Filing on Google Icon
8/13/2024Thrivent Financial for Lutherans30,009$0.78M0.0%-3.3%0.024%Search for SEC Filing on Google Icon
8/13/2024Sei Investments Co.9,908$0.26M0.0%-8.0%0.008%Search for SEC Filing on Google Icon
8/13/2024Pacer Advisors Inc.19,474$0.51M0.0%-2.4%0.016%Search for SEC Filing on Google Icon
8/12/2024Seven Eight Capital LP34,561$0.90M0.1%-54.1%0.028%Search for SEC Filing on Google Icon
8/12/2024Vanguard Personalized Indexing Management LLC12,751$0.33M0.0%+23.2%0.010%Search for SEC Filing on Google Icon
8/12/2024Amalgamated Bank60,052$1.56M0.0%-7.1%0.048%Search for SEC Filing on Google Icon
8/12/2024E Fund Management Co. Ltd.8,900$0.23M0.0%-31.3%0.007%Search for SEC Filing on Google Icon
8/10/2024Mutual of America Capital Management LLC71,111$1.85M0.0%-3.7%0.057%Search for SEC Filing on Google Icon
8/9/2024Edgestream Partners L.P.53,918$1.40M0.1%N/A0.043%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP145,874$3.79M0.0%+139.1%0.117%Search for SEC Filing on Google Icon
8/8/2024Federated Hermes Inc.7,201$0.19M0.0%-51.1%0.006%Search for SEC Filing on Google Icon
8/8/2024DekaBank Deutsche Girozentrale36,235$0.93M0.0%-4.3%0.029%Search for SEC Filing on Google Icon
8/8/2024Meeder Asset Management Inc.3,405$88K0.0%+4,629.2%0.003%Search for SEC Filing on Google Icon
8/8/2024State of New Jersey Common Pension Fund D81,323$2.11M0.0%-11.1%0.065%Search for SEC Filing on Google Icon
8/7/2024Texas Permanent School Fund Corp100,304$2.61M0.0%-7.5%0.081%Search for SEC Filing on Google Icon
8/5/2024Arizona State Retirement System34,685$0.90M0.0%+2.4%0.028%Search for SEC Filing on Google Icon
8/5/2024Victory Capital Management Inc.41,090$1.07M0.0%+67.3%0.033%Search for SEC Filing on Google Icon
8/3/2024TD Asset Management Inc54,200$1.41M0.0%+90.8%0.044%Search for SEC Filing on Google Icon
8/2/2024Wealth Effects LLC159,600$4.15M1.5%-3.0%0.129%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers383,029$9.96M0.0%+2.9%0.308%Search for SEC Filing on Google Icon
8/1/2024Privium Fund Management B.V.286,936$7.24M1.9%+4.7%0.231%Search for SEC Filing on Google Icon
7/31/2024nVerses Capital LLC3,700$96K0.1%N/A0.003%Search for SEC Filing on Google Icon
7/31/2024Commonwealth Equity Services LLC34,663$0.90M0.0%+3.7%0.028%Search for SEC Filing on Google Icon
7/29/2024Crossmark Global Holdings Inc.7,828$0.20M0.0%-6.3%0.006%Search for SEC Filing on Google Icon
7/29/2024Principal Financial Group Inc.424,766$11.04M0.0%-12.3%0.342%Search for SEC Filing on Google Icon
7/29/2024Zurcher Kantonalbank Zurich Cantonalbank28,739$0.75M0.0%+20.7%0.023%Search for SEC Filing on Google Icon
7/26/2024State of Michigan Retirement System29,870$0.78M0.0%-2.0%0.024%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Arrowhead Pharmaceuticals logo
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes Plozasiran, which is in Phase 2b and one Phase 3 clinical trial to treat hypertriglyceridemia, mixed dyslipidemia, and chylomicronemia syndrome; Zodasiran that is in Phase 2b clinical trial for the treatment of dyslipidemia and hypertriglyceridemia; ARO-PNPLA3, which is in Phase 1 clinical trial to treat patients with non-alcoholic steatohepatitis; ARO-RAGE that is in Phase 1/2a clinical trial to treat inflammatory pulmonary conditions; and ARO-MUC5AC, which is in Phase 1/2a clinical trial to treat muco-obstructive pulmonary diseases. It also develops ARO-MMP7 that is in Phase 1/2a clinical trial for treatment of idiopathic pulmonary fibrosis; ARO-DUX4 for the treatment of facioscapulohumeral muscular dystrophy; ARO-SOD1 for the potential treatment of amyotrophic lateral sclerosis; and ARO-C3, which is in Phase 1/2a clinical trial for the treatment of patients with various complement mediated or complement associated renal diseases. In addition, the company is involved in the development of JNJ-3989, which is in Phase 2 clinical trial to treat chronic hepatitis B virus infection; Olpasiran that is in Phase 3 clinical trial to reduce the production of apolipoprotein A; GSK-4532990 that is in phase 2 clinical trial to treat liver diseases; HZN-457, which is in phase 1 clinical trial to treat uncontrolled gout; and Fazirsiran that is in Phase 3 clinical trial for the treatment for liver disease associated with alpha-1 antitrypsin deficiency. Arrowhead Pharmaceuticals, Inc. has license and research collaboration agreements with Janssen Pharmaceuticals, Inc.; Takeda Pharmaceutical Company Limited; Horizon Therapeutics Ireland DAC; Amgen Inc.; and Glaxosmithkline Intellectual Property (No. 3) Limited. The company was founded in 2003 and is headquartered in Pasadena, California.
Read More on Arrowhead Pharmaceuticals

Today's Range

Now: $19.45
Low: $19.18
High: $20.21

50 Day Range

MA: $21.26
Low: $18.32
High: $26.34

52 Week Range

Now: $19.45
Low: $17.05
High: $39.83

Volume

4,010,988 shs

Average Volume

1,283,558 shs

Market Capitalization

$2.42 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.91

Who are the company insiders with the largest holdings of Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals' top insider shareholders include:
  1. Christopher Richard Anzalone (CEO)
  2. Patrick O'brien (COO)
  3. Kenneth Allen Myszkowski (CFO)
  4. James C Hamilton (Insider)
  5. Martin Javier San (Insider)
  6. Douglas B Given (Director)
  7. Tracie Oliver (Insider)
  8. William D Waddill (Director)
  9. Hongbo Lu (Director)
  10. Victoria Vakiener (Director)
  11. Adeoye Y Olukotun (Director)
Learn More about top insider investors at Arrowhead Pharmaceuticals.

Who are the major institutional investors of Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals' top institutional shareholders include:
  1. State Street Corp — 5.11%
  2. FMR LLC — 4.88%
  3. Geode Capital Management LLC — 2.38%
  4. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC — 1.73%
  5. Charles Schwab Investment Management Inc. — 0.81%
  6. Jane Street Group LLC — 0.37%
Learn More about top institutional investors of Arrowhead Pharmaceuticals stock.

Which institutional investors are selling Arrowhead Pharmaceuticals stock?

During the last quarter, ARWR stock was sold by these institutional investors:
  1. FMR LLC
  2. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
  3. Principal Financial Group Inc.
  4. Principal Financial Group Inc.
  5. Jane Street Group LLC
  6. Ontario Teachers Pension Plan Board
  7. WCM Investment Management LLC
  8. Exchange Traded Concepts LLC
In the last year, company insiders that have sold Arrowhead Pharmaceuticals company stock include:
  1. Christopher Richard Anzalone (CEO)
  2. Patrick O'brien (COO)
  3. Kenneth Allen Myszkowski (CFO)
  4. James C Hamilton (Insider)
  5. Martin Javier San (Insider)
  6. Douglas B Given (Director)
  7. Tracie Oliver (Insider)
  8. William D Waddill (Director)
Learn More investors selling Arrowhead Pharmaceuticals stock.

Which institutional investors are buying Arrowhead Pharmaceuticals stock?

Within the last quarter, ARWR stock was acquired by institutional investors including:
  1. State Street Corp
  2. Assenagon Asset Management S.A.
  3. abrdn plc
  4. Fisher Asset Management LLC
  5. International Assets Investment Management LLC
  6. Erste Asset Management GmbH
  7. Privium Fund Management B.V.
  8. Verition Fund Management LLC
I was wrong. Dead wrong.
From Porter & Company   |   Ad
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Here’s the full story for you.